{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:01:52Z","timestamp":1790665312766,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1D1A1A09081884"],"award-info":[{"award-number":["2018R1D1A1A09081884"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2016R1D1A1B01010508"],"award-info":[{"award-number":["2016R1D1A1B01010508"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SMC-SKKU Future Convergence Program","award":["SMO1190341"],"award-info":[{"award-number":["SMO1190341"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.cyto.2020.155213","type":"journal-article","created":{"date-parts":[[2020,7,28]],"date-time":"2020-07-28T15:15:04Z","timestamp":1595949304000},"page":"155213","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["WNT5A augments cell invasiveness by inducing CXCL8 in HER2-positive breast cancer cells"],"prefix":"10.1016","volume":"135","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3466-8634","authenticated-orcid":false,"given":"Sangmin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daeun","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisun","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Young","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung A","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jin","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Eon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2020.155213_b0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3389\/fonc.2018.00156","article-title":"Efficacy of Anti-HER2 Agents in Combination With Adjuvant or Neoadjuvant Chemotherapy for Early and Locally Advanced HER2-Positive Breast Cancer Patients: A Network Meta-Analysis","volume":"8","author":"Debiasi","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.cyto.2020.155213_b0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41392-019-0069-2","article-title":"Targeted therapeutic options and future perspectives for HER2-positive breast cancer","volume":"4","author":"Wang","year":"2019","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.cyto.2020.155213_b0015","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1158\/0008-5472.CAN-11-3594","article-title":"HER3 is required for HER2-induced preneoplastic changes to the breast epithelium and tumor formation","volume":"72","author":"Vaught","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2020.155213_b0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejps.2017.01.021","article-title":"Discovery and development of pyrotinib: A novel irreversible EGFR\/HER2 dual tyrosine kinase inhibitor with favorable safety profiles for the treatment of breast cancer","volume":"110","author":"Li","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.cyto.2020.155213_b0025","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-11-3747","article-title":"MEK inhibition leads to PI3K\/AKT activation by relieving a negative feedback on ERBB receptors","volume":"72","author":"Turke","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2020.155213_b0030","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1200\/JCO.2007.11.6699","volume":"26","author":"Seidman","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cyto.2020.155213_b0035","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1586\/era.10.226","article-title":"HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies","volume":"11","author":"Gajria","year":"2011","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.cyto.2020.155213_b0040","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1002\/jcp.29216","article-title":"Overcoming trastuzumab resistance in HER2-positive breast cancer using combination therapy","volume":"235","author":"Derakhshani","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.cyto.2020.155213_b0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.cca.2017.06.017","article-title":"Wnt5a and its signaling pathway in angiogenesis","volume":"471","author":"Shi","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cyto.2020.155213_b0050","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2009.02.003","article-title":"Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells","volume":"137","author":"Yamamoto","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cyto.2020.155213_b0055","doi-asserted-by":"crossref","first-page":"12273","DOI":"10.18632\/oncotarget.2631","article-title":"Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA\/beta-catenin pathway","volume":"5","author":"Hung","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.cyto.2020.155213_b0060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1499-3872(14)60277-0","article-title":"WNT5A modulates cell cycle progression and contributes to the chemoresistance in pancreatic cancer cells","volume":"13","author":"Wei","year":"2014","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.cyto.2020.155213_b0065","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10549-009-0674-9","article-title":"An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients","volume":"123","author":"Gyorffy","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.cyto.2020.155213_b0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.phymed.2018.08.004","article-title":"Berberine down-regulates IL-8 expression through inhibition of the EGFR\/MEK\/ERK pathway in triple-negative breast cancer cells","volume":"50","author":"Kim","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cyto.2020.155213_b0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cbi.2016.08.021","article-title":"Elevated IL-1beta expression induces invasiveness of triple negative breast cancer cells and is suppressed by zerumbone","volume":"258","author":"Jeon","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cyto.2020.155213_b0080","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/carcin\/bgq269","article-title":"beta-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis","volume":"32","author":"Klemm","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cyto.2020.155213_b0085","doi-asserted-by":"crossref","first-page":"7163","DOI":"10.1038\/sj.onc.1210528","article-title":"ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines","volume":"26","author":"Ginestier","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.cyto.2020.155213_b0090","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.7150\/jca.18457","article-title":"Breast Cancer Cell Line Classification and Its Relevance with Breast Tumor Subtyping","volume":"8","author":"Dai","year":"2017","journal-title":"J Cancer"},{"key":"10.1016\/j.cyto.2020.155213_b0095","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc3419","article-title":"WNT signalling pathways as therapeutic targets in cancer","volume":"13","author":"Anastas","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cyto.2020.155213_b0100","doi-asserted-by":"crossref","first-page":"20979","DOI":"10.18632\/oncotarget.24761","article-title":"Wnt5a-induced cell migration is associated with the aggressiveness of estrogen receptor-positive breast cancer","volume":"9","author":"Kobayashi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.cyto.2020.155213_b0105","first-page":"409","article-title":"Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas","volume":"62","author":"Jonsson","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.cyto.2020.155213_b0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1535-6108(02)00045-4","article-title":"Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma","volume":"1","author":"Weeraratna","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cyto.2020.155213_b0115","first-page":"515","article-title":"Frequent up-regulation of WNT5A mRNA in primary gastric cancer","volume":"9","author":"Saitoh","year":"2002","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cyto.2020.155213_b0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.joca.2010.10.016","article-title":"Requirement of the NF-kappaB pathway for induction of Wnt-5A by interleukin-1beta in condylar chondrocytes of the temporomandibular joint: functional crosstalk between the Wnt-5A and NF-kappaB signaling pathways","volume":"19","author":"Ge","year":"2011","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.cyto.2020.155213_b0125","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/jbmr.1488","article-title":"WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production","volume":"27","author":"Rauner","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.cyto.2020.155213_b0130","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3121\/cmr.2008.825","article-title":"Breast cancer subtypes based on ER\/PR and Her2 expression: comparison of clinicopathologic features and survival","volume":"7","author":"Onitilo","year":"2009","journal-title":"Clin. Med. Res."},{"key":"10.1016\/j.cyto.2020.155213_b0135","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/1535-7163.MCT-11-0682","article-title":"An anti-Wnt5a antibody suppresses metastasis of gastric cancer cells in vivo by inhibiting receptor-mediated endocytosis","volume":"11","author":"Hanaki","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.cyto.2020.155213_b0140","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171092","article-title":"Wnt5a promotes epithelial-to-mesenchymal transition and metastasis in non-small-cell lung cancer","volume":"37","author":"Wang","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.cyto.2020.155213_b0145","first-page":"367","article-title":"A second canon","volume":"5","author":"Veeman","year":"2003","journal-title":"Functions and mechanisms of beta-catenin-independent Wnt signaling, Dev Cell"},{"key":"10.1016\/j.cyto.2020.155213_b0150","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.4049\/jimmunol.1000181","article-title":"Wnt5a induces endothelial inflammation via beta-catenin-independent signaling","volume":"185","author":"Kim","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2020.155213_b0155","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s002620050605","article-title":"Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-kappaB- and AP-1-dependent mechanism","volume":"49","author":"Collins","year":"2000","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.cyto.2020.155213_b0160","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1007\/s13277-015-4345-7","article-title":"MEK-dependent IL-8 induction regulates the invasiveness of triple-negative breast cancer cells","volume":"37","author":"Kim","year":"2016","journal-title":"Tumour Biol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620302295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466620302295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T20:57:47Z","timestamp":1760907467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466620302295"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":32,"alternative-id":["S1043466620302295"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155213","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"WNT5A augments cell invasiveness by inducing CXCL8 in HER2-positive breast cancer cells","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2020.155213","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155213"}}